BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12435290)

  • 1. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial.
    Heys SD; Hutcheon AW; Sarkar TK; Ogston KN; Miller ID; Payne S; Smith I; Walker LG; Eremin O;
    Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S69-74. PubMed ID: 12435290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.
    Smith IC; Heys SD; Hutcheon AW; Miller ID; Payne S; Gilbert FJ; Ah-See AK; Eremin O; Walker LG; Sarkar TK; Eggleton SP; Ogston KN
    J Clin Oncol; 2002 Mar; 20(6):1456-66. PubMed ID: 11896092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant docetaxel in locally advanced breast cancer.
    Hutcheon AW; Heys SD; Sarkar TK;
    Breast Cancer Res Treat; 2003; 79 Suppl 1():S19-24. PubMed ID: 12868802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary chemotherapy with docetaxel for the management of breast cancer.
    Valero V
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):35-43. PubMed ID: 12108896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.
    Jackisch C; von Minckwitz G; Eidtmann H; Costa SD; Raab G; Blohmer JU; Schütte M; Gerber B; Merkle E; Gademann G; Lampe D; Hilfrich J; Tulusan AH; Caputo A; Kaufmann M
    Clin Breast Cancer; 2002 Oct; 3(4):276-80. PubMed ID: 12425756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
    Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
    J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Docetaxel was effective as neoadjuvant chemotherapy for patients after failure of trans-arterial neoadjuvant chemotherapy with CEF in 2 cases of advanced breast cancer].
    Ogawa T; Nagata S; Suzuki H; Onzuka T; Yamanaka N; Kawano R; Yoshida J; Shinohara M; Sumitomo K; Matsuo K; Kuroki S
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1743-5. PubMed ID: 11708023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.
    Ferreira Filho AF; Crown J; Cardoso F; Nogaret JM; Duffy K; Dolci S; Rowan S; O'Higgins N; Batter V; Paesmans M; Piccart MJ; Di Leo A
    Anticancer Res; 2002; 22(4):2471-6. PubMed ID: 12174946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
    Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
    Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel in the treatment of breast cancer: an update on recent studies.
    Nabholtz JM; Reese DM; Lindsay MA; Riva A
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):28-34. PubMed ID: 12170449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel: an update of its use in advanced breast cancer.
    Figgitt DP; Wiseman LR
    Drugs; 2000 Mar; 59(3):621-51. PubMed ID: 10776837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer.
    Walker LG; Eremin JM; Aloysius MM; Vassanasiri W; Walker MB; El-Sheemy M; Cowley G; Beer J; Samphao S; Wiseman J; Jibril JA; Valerio D; Clarke DJ; Kamal M; Thorpe GW; Baria K; Eremin O
    BMC Cancer; 2011 May; 11():179. PubMed ID: 21592370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer.
    Cheng M; Song Z; Qi Y; Wang X; Zhang L; Shi J; Wang M
    Oncol Res Treat; 2019; 42(5):269-274. PubMed ID: 30943501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel (Taxotere) in combination: a step forward.
    Burris HA; Fields S; Peacock N
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
    Gradishar WJ
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects with docetaxel in the treatment of patients with breast cancer.
    Marty M; Extra JM; Cottu PH; Espié M
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S26-9. PubMed ID: 9486101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.
    Ganem G; Tubiana-Hulin M; Fumoleau P; Combe M; Misset JL; Vannetzel JM; Bachelot T; De Ybarlucea LR; Lotz V; Bendahmane B; Dieras V
    Ann Oncol; 2003 Nov; 14(11):1623-8. PubMed ID: 14581269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.